A Randomized Controlled Trial Study Comparing Adnexal Surgery by vNOTES or Laparoscopy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRegion Skane

About this trial

The aim with the study is to compare postoperative pain after vNOTES adnexal surgery versus laparoscopic adnexal surgery.

Women aged 18 and above with an indication for adnexal surgery for benign gynecological pathology or prophylactic reasons will be able to participate.

After surgery the participants will answer a questioner, twice a day in seven days, about postoperative pain and how many units of analgesics they used.

Adnexal surgery is one of the most common surgical procedures performed in women and can either be performed to treat pathology as ovarian cysts or prophylactically in case of hereditary genetic alterations.

A laparoscopic technique is currently considered as gold standard for adnexal procedures. The latest advancement in minimally invasive surgery is vNOTES (vaginal natural orifice transluminal endoscopy), in which the entrance to the abdomen is performed by an anterior or more commonly posterior colpotomy rather than via the abdominal wall. The NOTABLE trial was a RCT showing that vNOTES adnexectomy was non-inferior to laparoscopy for successful removal of benign adnexa without conversion (Baekelandt). vNOTES adnexectomy had shorter surgical time, less use of analgesics and lower self-assessed VAS scores the first week post-operatively. The aim with our study is to compare postoperative pain after vNOTES versus laparoscopic adnexal surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participant is willing and able to give informed consent for participation in the trial.

Female aged 18 years or above.

Diagnosed with adnexal pathology or subject for prophylactic BSO.

Disqualifiers

Female participant who is pregnant or planning pregnancy during course of the trial.

Scheduled elective surgery or other procedures requiring general anaesthesia during the trial.

Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.

Patients taking opioids or other painkillers routinely pre-operatively.

Trial design

Design model

Parallel

Treatments tested in this trial

  • vNOTES adnexal surgery

    Procedure/Surgery

    New minimalinvasive technique

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Laparoscopic Adnexal surgeryActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain postoperatively by a VAS-scale

To compare postoperative pain after adnexal surgery performed by vNOTES or laparoscopy

Time frame
7 days postoperative

Secondary outcomes

1

Painkillers used (amount)

Units of non-opioid analgesics Units of postoperative opioids

Time frame
7 days postoperatively
2

Perioperatively complications

The incidence of intra-operative complications, i.e. any adverse event before the end of the surgical intervention including injury to the bladder, ureter, bowel, or intrapelvic/intra-abdominal vessels, as a dichotomous outcome.

Time frame
Perioperatively
3

Operation time

Operation time, measured as the time in minutes from the insertion of the bladder catheter to the end of vaginal/abdominal wound closure, as a continuous outcome.

Time frame
Perioperatively
4

Postoperative complications

Postoperative complications: major bleeding or pelvic hematoma requiring transfusion. Infections of the vaginal incision, abdominal wall or wound, urinary tract, chest, or febrile episodes/unspecified infections. Thromboembolism. Postoperative ileus or wound dehiscence. Classified according to the Clavien- Dindo, classification as a dichotomous outcome.

Time frame
6 weeks postoperatively

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: